Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and R-MACLO/IVAM in untreated mantle cell lymphoma
NCT00878254Phase 2Completed
- Sponsor
- University of Miami
- Start
- Mar 2009
- Primary completion
- Jun 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in mantle cell lymphoma (MCL), sponsored by University of Miami. Started Mar 2009; status: completed.
02
Drugs
rituximab
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00878254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00878254.